A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Findings highlight the Pfizer ... vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback